1-1 of 1
interleukin 6 receptor
Close
Sort by
Journal Articles

Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR -mutated MPNs

Manjola Balliu, Laura Calabresi, Niccolò Bartalucci, Simone Romagnoli, Laura Maggi, Rossella Manfredini, Matteo Lulli, Paola Guglielmelli, Alessandro Maria Vannucchi
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2184–2195.
https://doi.org/10.1182/bloodadvances.2020003291
Published: 2021
Includes: Supplemental data